Latest Us Market News

Page 4 of 72
Botanix Pharmaceuticals has agreed to terms with Piramal to establish an alternate supplier for the active ingredient in Sofdra, aiming to reduce costs by up to 40% and strengthen its supply chain.
Ada Torres
Ada Torres
16 Apr 2026
ReNerve has moved its NervAlign Nerve Guide Matrix into stage 3 of commercial development, a key step toward FDA submission and eventual market entry. This progress supports the company’s ambition to provide surgeons with an alternative to donor nerves for repairing severe peripheral nerve injuries.
Ada Torres
Ada Torres
15 Apr 2026
PainChek has secured a landmark agreement with Sabra Health Care REIT to deploy its AI-powered pain assessment across up to 20,000 beds in North America, marking a pivotal step in its US expansion.
Ada Torres
Ada Torres
14 Apr 2026
Harvest Technology Group has secured independent validation of its Nodestream platform's strong fit within the US defence sector, highlighting a clear pathway for market entry focused on bandwidth-constrained communications.
Sophie Babbage
Sophie Babbage
14 Apr 2026
Clarity Pharmaceuticals has secured a major manufacturing deal with Nucleus RadioPharma to produce its next-generation prostate cancer imaging agent, 64Cu-SAR-bisPSMA, ramping up supply ahead of anticipated US market entry.
Ada Torres
Ada Torres
14 Apr 2026
WhiteHawk (ASX: WHK) has acquired Quixxi, gaining the Clarity AI platform to extend its cybersecurity services into the burgeoning global AI governance sector. The deal positions WhiteHawk at the convergence of cybersecurity, data governance, and AI risk management amid rapid market growth and regulatory momentum.
Sophie Babbage
Sophie Babbage
13 Apr 2026
Dalaroo Metals has launched trading on the US OTCQB market, broadening its investor reach without diluting shares, while progressing its Greenland rare earth project with promising exploration results.
Maxwell Dee
Maxwell Dee
13 Apr 2026
ARB Corporation Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.34 per share for the six months ending 31 December 2025, alongside Dividend Reinvestment Plan (DRP) and Bonus Security Plan (BSP) pricing.
Victor Sage
Victor Sage
10 Apr 2026
Lumos Diagnostics Holdings Limited (ASX: LDX) has opened a Share Purchase Plan (SPP) offering eligible shareholders the chance to invest up to A$30,000 at A$0.225 per share, accompanied by free options. The SPP aims to raise up to A$2 million and closes on 24 April 2026.
Ada Torres
Ada Torres
10 Apr 2026
Lumos Diagnostics has entered a three-year contract manufacturing agreement with Micro-Pak to produce the Mold Analyzer system, marking a transition from development to commercial-scale manufacturing with an initial US$250,000 purchase order.
Ada Torres
Ada Torres
8 Apr 2026
InFocus Group Holdings Limited (ASX: IFG) has unveiled a global technical preview of Codexa, its proprietary sweepstakes casino platform, marking a key step towards commercial operations in the US market. The platform features advanced technology including blockchain fairness verification and AI-driven personalisation.
Sophie Babbage
Sophie Babbage
8 Apr 2026
Imricor Medical Systems has submitted its NorthStar Mapping System for FDA pediatric label expansion, aiming to accelerate adoption in over 250 US children’s hospitals and broaden its commercial footprint.
Ada Torres
Ada Torres
8 Apr 2026